- cross-posted to:
- [email protected]
- cross-posted to:
- [email protected]
Summary
Over 250 branded drugs in the U.S. will see price increases starting Jan. 1, 2025, with most hikes below 10% and a median increase of 4.5%.
Key companies like Pfizer, Bristol Myers Squibb, and Sanofi are raising prices on treatments for COVID-19, cancer, and vaccines, citing R&D costs and inflation.
Some prices, such as Merck’s diabetes drugs, will be reduced.
Critics highlight that U.S. drug prices remain the highest globally, while manufacturers face pressure to moderate year-over-year price hikes.
If the pharmaceutical executives are so confident that making these types decisions is necessary…Then why won’t they get on a podium in a public space on live TV and explain they’re reasoning to the very people it’s going to effect the most?
If it’s really that important there should be no issue with the public’s response.